Abstract:Abstract Background and Aims The proximal tubule has a capacity for repair after acute kidney injury (AKI), but this capacity is limited, especially in severe AKI. Tubular maladaptive repair after AKI leads to chronic kidney disease (CKD), even to end-stage renal disease (ESRD). However, the mechanism of maladaptive repair is not fully clarified, and there is a lack of effective treatment for AKI in clinic. Our previous study found that decoy receptor 2 (DcR2), a trans-membrane receptor of tumor necrosis factor-related apoptosis inducing ligand (TRAIL), was specifically expressed renal tubules and did not have the ability of proliferation in AKI, suggesting DcR2 may be associated with maladaptive repair of tubular cells. This study aims to investigate the role and mechanism of DcR2-positive tubular cells in the repair of AKI. Method The DcR2-GFP lineage trace mice,KSP-creDcR2f/f mice (Distal tubular DcR2 Conditional Knockout CKO) mice and GGT1-creDcR2f/f (proximal tubular DcR2 Conditional Knockout CKO) mice were constructed, and three AKI mouse models (moderate and severe ischemia-reperfusion injury and cisplatin-induced AKI) were conducted. Light microscopic examination of paraffin-embedded sections stained with haematoxylin and eosin, periodic acid–Schiff stain and Masson stain. Confocal analysis the co-expression of DcR2-GFP and proximal tubular markers(AQP1, Villin), distal markers (AQP2), failed repair markers (Vcam1, Dcdc2), proliferative markers (Ki-67, Edu, PCNA), Kim1, differentiated markers (pax2, sox9, six2), senescent markers (P16, P21, SA-β-gal), senescent phenotype (IL-6, TGF-β1) and fibrotic markers (a-SMA, collagen I, Fibronectin). And wild type (WT) mice and DcR2 CKO mice were used to compare the degree of kidney injury, renal function and tubular repair after AKI. Furthermore, quantitative proteomics and bioinformatics analyzed the downstream molecules of DcR2 in renal tissues from WT-AKI and CKO-AKI, and validated studied were done. Results In this study, we found decoy receptor DcR2 was highly expressed in renal tubules and associated with kidney damage in AKI patients and mouse models. DcR2-GFP transgenic mice verified that DcR2 was specifically expressed in proximal tubular epithelial cells (PTECs) after AKI. The levels of Scr, BUN and urinary DcR2 and renal acute and chronic injury scores were significantly lower inGGT1-creDcR2f/f -AKI than that of WT-AKI. Meanwhile, the proliferative markers, senescent markers and area of renal fibrosis and fibrotic markers expression was decreased inGGT1-creDcR2f/f mice compared with WT. However, the above effects were not obviously improved in KSP-creDcR2f/f mice after AKI. These results suggested that proximal tubular DcR2 knockout alleviated kidney injury and promote tubular repair after AKI. Consistent with findings in vivo, DcR2 promoted cell senescence and inhibited cell proliferation in hypoxia-reoxygenation and cisplatin-treated primary PTECs. Further quantitative proteomics and validated studies showed Hmgcs2, a key enzyme for ketone synthesis, was increased in GGT1-creDcR2f/f mice compared with WT. And the levels of urinary and renal β-hydroxybutyrate (β-OHB) were higher inGGT1-creDcR2f/f mice, suggesting DcR2 affects the synthesis of β-hydroxybutyrate through regulating the expression of Hmgcs2. Inhibition or deletion of Hmgcs2 aggravated kidney damage and repressed renal repair, but administration with β-OHB rescued these phenomena. Subsequently, PTEC-specific DcR2/Hmgcs2 double deletion decreased β-OHB levels, which inhibited FOXO3 signaling by regulating histone acetylation, thereby boosting tubular maladaptive repair after AKI. Conclusion DcR2 promotes maladaptive repair of tubular cells by regulating Hmgcs2-induced β-OHB production, and β-OHB affects FOXO3 signaling by regulating histone acetylation. The findings suggests that DcR2/Hmgcs2/ketogenesis/FOXO3 signaling mediates tubular maladaptive repair, and DcR2 could serve as a promising target for improving renal repair and AKI prognosis.

Renal tubule mTORC2 deletion increases gluconeogenesis and urinary glucose excretion

Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium

Rictor/mTORC2 is Essential for Maintaining a Balance Between Β-Cell Proliferation and Cell Size

Conditional ablation of glycogen synthase kinase 3 β in postnatal mouse kidney

Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis

mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b

The Mtorc2/pkc Pathway Sustains Compensatory Insulin Secretion of Pancreatic Β Cells in Response to Metabolic Stress

Mtorc1 Alters the Expression of Glycolytic Genes by Regulating Kpna2 Abundances

Characterizing Murine Diabetic Glucose Metabolism Under Conditions of Attenuated Renal Glucose Reabsorption

Abstract 002: Macula Densa SGLT1-NOS1-TGF Pathway -- A New Mechanism for Glomerular Hyperfiltration in Diabetes

Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes

Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function

Renal tubule-specific Atgl deletion links kidney lipid metabolism to glucagon-like peptide 1 and insulin secretion independent of renal inflammation or lipotoxicity

A kidney-hypothalamus axis promotes compensatory glucose production in response to glycosuria

cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis

Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium–Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice

Mtorc2 is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation

Sodium-Glucose Co-Transporter 2 Inhibitors Correct Metabolic Maladaptation of Proximal Tubular Epithelial Cells in High-Glucose Conditions

PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models

#3665 DCR2 PROMOTES TUBULAR MALADAPTIVE REPAIR BY INHIBITING KETONE BODY–INDUCED FOXO3 SIGNALING AFTER ACUTE KIDNEY INJURY

Hepatic Traf2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses